DIFFERENTIAL DIAGNOSIS BETWEEN KAWASAKI DISEASE AND ACUTE INFECTIOUS DISEASES – A CASE REPORT

Authors

DOI:

https://doi.org/10.21272/eumj.2025;13(1):315-322

Keywords:

Kawasaki disease, acute respiratory viral infection, tonsillitis, children

Abstract

Introduction. Kawasaki disease is a relatively rare but severe acute febrile disease characterized by vasculitis. It represents a unique challenge in pediatrics due to its potential for coronary artery complications and the necessity for prompt recognition and treatment.

Materials and methods. The study was conducted at the Ivano-Frankivsk Regional Children Clinical Hospital of the Ivano-Frankivsk Regional Council. A clinical case of Kawasaki disease in a child was analyzed. The research was carried out in accordance with the principles of the Helsinki Declaration. The research protocol was approved by the Local Ethics Committee of the institution. Informed consent of the child's parents was obtained for the research.

Case presentation. We are presenting a clinical case of Kawasaki disease in a 5-year-old Ukrainian girl who was diagnosed with acute respiratory disease, tonsillopharyngitis. After the antibacterial therapy, a spotted-papular rash appeared, and the doctor suspected infectious mononucleosis. On the 7th day of the illness, signs of conjunctivitis and pain in the lower extremities appeared, and on the 8th day of the disease, the child was referred to a hospital. Based on the clinical signs and test results, the final diagnosis of Kawasaki disease was established. Upon admission, mild anemia (hemoglobin – 100 g/L), leukocytosis (16.86×109/L), thrombocytosis (1147×109/L), and an elevated erythrocyte sedimentation rate (105 mm/h) were detected. Biochemical blood tests revealed hypoalbuminemia (34.9–10.8 g/L), a decreased A/G index (0.12), and significantly increased D-dimer (6051.3 μg/ml) and C-reactive protein (185.1 mg/l) levels. Echocardiographic examination revealed expansion of the coronary arteries and regurgitation of the tricuspid valve. The patient received intravenous human immunoglobulin 10% at a dosage of 2 g/kg IV for 3 days, acetylsalicylic acid, 10 mg/kg ibuprofen, infusion therapy with glucose-salt solutions, and oral rehydration. Against the background of treatment, the child's condition stabilized, and on the 10th day after admission, with improvement, she was discharged from the hospital.

Conclusion. The present case demonstrates that patients with Kawasaki disease need a multidisciplinary approach for timely diagnosis and treatment. Disease manifestations are nonspecific, and doctors often consider them to be signs of more common conditions, such as acute respiratory infections, tonsillitis, and infectious mononucleosis.

Downloads

Download data is not yet available.

References

Guidelines for Diagnosis and Management of Cardiovascular Sequelae in Kawasaki Disease (JCS 2013). Circulation Journal. 2014;78(10):2521–62. Retrieved from: https://www.jstage.jst.go.jp/article/circj/78/10/78_CJ-66-0096/_article

Ravelli A, Martini A. Kawasaki disease or Kawasaki syndrome? Annals of the Rheumatic Diseases. 2020 Jun 22;79(8):993–5. Retrieved from: https://ard.bmj.com/content/79/8/993

Kuo HC, editor. Kawasaki Disease. Singapore: Springer Nature Singapore; 2022. Retrieved from: https://link.springer.com/book/10.1007/978-981-19-2944-1

Kanecki K., Mikolajczyk M., Tyszko P. Kawasaki disease: increasing incidence in Poland. Scandinavian Journal of Rheumatology. 2016. 45(1):82—3. Retrieved from: https://www.tandfonline.com/doi/citedby/10.3109/03009742.2015.1085082?scroll=top&needAccess=true

McCrindle et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease. Circulation. 2017. 135. 927-99 Retrieved from: https://www.ahajournals.org/doi/10.1161/CIR.0000000000000484

Nakamura Y., Yashiro M., Uehara R. et al. Epidemiologic features of Kawasaki disease in Japan: results of the 2007—2008 nationwide survey. J Epidemiol. 2010. 20(4): 302-7. Retrieved from: https://www.jstage.jst.go.jp/article/jea/20/4/20_JE20090180/_article

Wang CL. Introduction and History of Kawasaki Disease. In: Kuo H-C, editor. Kawasaki Disease. Singapore: Springer; 2022. Retrieved from: https://link.springer.com/chapter/10.1007/978-981-19-2944-1_1

Rowley AH. Is Kawasaki disease an infectious disorder? Int J Rheum Dis. 2018;21(1):20–5. Retrieved from: http://dx.doi.org/10.1111/1756-185x.13213

Shakeel S, Ahmad Hassali MA. Post-COVID-19 outbreak of severe Kawasaki-like multisystem inflammatory syndrome in children. Malays J Med Sci [Internet]. 2021;28(1):109–16. Retrieved from: http://dx.doi.org/10.21315/mjms2021.28.1.14

Downloads

Published

2025-03-29

How to Cite

Mateiko, H. B. ., Pylyuk, I. I. ., Matvisiv, M. V. ., Horbal, N. B. ., & Berezna, T. H. . (2025). DIFFERENTIAL DIAGNOSIS BETWEEN KAWASAKI DISEASE AND ACUTE INFECTIOUS DISEASES – A CASE REPORT. Eastern Ukrainian Medical Journal, 13(1), 315–322. https://doi.org/10.21272/eumj.2025;13(1):315-322

Issue

Section

CLINICAL CASE. INFECTIOUS DISEASES